☆ 4.7 Letter

Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases

LEUKEMIA (2013)

Journal

LEUKEMIA

Volume 27, Issue 4, Pages 982-985

Publisher

NATURE PUBLISHING GROUP

DOI: 10.1038/leu.2012.267

Keywords

-

Categories

Oncology Hematology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Pathology

Myeloid somatic mutation panel testing in myeloproliferative neoplasms

David M. Ross, Candice Thomson, Nada Hamad, Steven W. Lane, Kate Manos, Andrew P. Grigg, Belinda Guo, Wendy N. Erber, Ashleigh Scott, Nick Viiala, Lynette Chee, Maya Latimer, Courtney Tate, Carolyn Grove, Andrew C. Perkins, Piers Blombery

Summary: Myeloproliferative neoplasms are characterized by somatic mutations in pathways regulating cell proliferation, epigenetic modifications, RNA splicing, or DNA repair. Assessment of mutational profile aids in diagnosis, classification, prognosis evaluation, and guiding targeted therapy. Massively parallel sequencing, especially disease-specific next generation sequencing panels, is the most effective way to provide information on various genetic variants.

PATHOLOGY (2021)

Add to Collection

Article Oncology

Philadelphia-negative myeloproliferative neoplasms among Kuwaiti Nationals

Salem Alshemmari, Mazyad Almazyad, Aisha Alwehaib, Reem Ameen

Summary: The study investigated the epidemiology of Ph-negative MPNs among Kuwaiti nationals, revealing ET as the most common subtype and JAK2V617F as the most common driver mutation. A significant percentage of patients (19.2%) presented with thrombosis at diagnosis, with males more likely to have arterial thrombosis and females more likely to have venous thrombosis.

CANCER MEDICINE (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Molecular Pathogenesis of Myeloproliferative Neoplasms: From Molecular Landscape to Therapeutic Implications

Erika Morsia, Elena Torre, Antonella Poloni, Attilio Olivieri, Serena Rupoli

Summary: Despite their differences in clinical presentation, myeloproliferative neoplasms (MPN) share similarities in morphology, propensity for thrombotic events and leukemia transformation, and a complex molecular pathogenesis. Key driver mutations, such as JAK2, MPL, and CALR, activate the JAK-STAT signaling pathway, which is characteristic of MPN pathogenesis. Recent research has revealed the presence of co-occurring somatic mutations associated with epigenetic regulation, mRNA splicing, transcriptional mechanisms, signal transduction, and DNA repair mechanisms in MPN patients. Integrating genetic information into clinical practice has already improved disease monitoring and provided prognostic information regarding disease progression. While current therapeutic approaches have limited disease-modifying activity, a deeper understanding of the genetic basis of MPN has identified potential targets for targeted therapies. This review aims to explore the molecular landscape of MPN, providing a comprehensive overview of driver mutations, additional mutations, their impact on pathogenesis, prognostic value, and future implications for therapeutic management.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Review Immunology

Immune Phenomena in Myeloid Neoplasms: An Egg or Chicken Question

Wilma Barcellini, Bruno Fattizzo

Summary: Immune phenomena, including autoimmune diseases and immunodeficiency, are increasingly reported in myeloid neoplasms. These dysregulated immune responses may contribute to both tumor growth and infection susceptibility. Therapies aimed at boosting host immunity against tumors may lead to increased autoimmune complications.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Article Oncology

Germline ATG2B/GSKIP-containing 14q32 duplication predisposes to early clonal hematopoiesis leading to myeloid neoplasms

Jean Pegliasco, Pierre Hirsch, Christophe Marzac, Francoise Isnard, Jean-Come Meniane, Caroline Deswarte, Philippe Pellet, Celine Lemaitre, Gwendoline Leroy, Graciela Rabadan Moraes, Helene Guermouche, Barbara Schmaltz-Panneau, Florence Pasquier, Chrystelle Colas, Patrick R. Benusiglio, Odile Bera, Jean-Henri Bourhis, Eolia Brissot, Olivier Caron, Samy Chraibi, Pascale Cony-Makhoul, Christine Delaunay-Darivon, Simona Lapusan, Flore Sicre de Fontbrune, Pascal Fuseau, Albert Najman, William Vainchenker, Francois Delhommeau, Jean-Baptiste Micol, Isabelle Plo, Christine Bellanne-Chantelot

Summary: The study revealed that carriers of the 14q32 duplication displayed early clonal hematopoiesis, increasing the risk of myeloid neoplasms. Different pathways were identified in the development of the disease, with one leading to early MPN development and the other directly to AML.

LEUKEMIA (2022)

Add to Collection

Review Oncology

Molecular Mechanisms of Senescence and Implications for the Treatment of Myeloid Malignancies

Philipp Ernst, Florian H. Heidel

Summary: Cellular senescence is a cellular program in response to stress, with both anti-tumorigenic and pro-tumorigenic effects. It is involved in aging-associated diseases and can prevent the development of pre-cancerous lesions and tumor growth. Senescent cells secrete factors that contribute to both early anti-tumorigenic effects and long-term pro-tumorigenic effects.

CANCERS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Clinical and prognostic profile of SRSF2 and related spliceosome mutations in patients with acute myeloid leukemia

Wenbo Jia, Xiaodong Guo, Yihong Wei, Jinting Liu, Can Can, Ruiqing Wang, Xinyu Yang, Chunyan Ji, Daoxin Ma

Summary: In this study, SF mutations were frequently detected in newly diagnosed non-M3 AML patients, with 64 out of 368 patients harboring SF mutations. SF mutations were more commonly found in older or male patients. SRSF2 mutations were shown to co-exist with IDH2 mutations. SF-mutated patients had higher measurable residual disease levels after first chemotherapy and a significantly decreased complete remission rate. The overall survival of SF-mutated patients was shorter than that of SF-wild patients.

MOLECULAR BIOLOGY REPORTS (2023)

Add to Collection

Article Chemistry, Medicinal

Targeting Autophagy-Related Epigenetic Regulators for Cancer Drug Discovery

Yang Li, Gaoxia Yang, Chengcan Yang, Pan Tang, Juncheng Chen, Jifa Zhang, Jie Liu, Liang Ouyang

Summary: Epigenetic modifications have been shown to regulate autophagy and the expression of tumor-associated genes, promoting tumor progression. Targeting autophagy with emerging epigenetic drugs is a promising therapeutic strategy for tumors.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Add to Collection

Review Cell Biology

Impact of Molecular Biology in Diagnosis, Prognosis, and Therapeutic Management of BCR::ABL1-Negative Myeloproliferative Neoplasm

Norman Abbou, Pauline Piazzola, Jean Gabert, Vincent Ernest, Robin Arcani, Anne-Laure Couderc, Antoine Tichadou, Pauline Roche, Laure Farnault, Julien Colle, L'houcine Ouafik, Pierre Morange, Regis Costello, Geoffroy Venton

Summary: BCR-ABL1-negative myeloproliferative neoplasms (MPNs) include three major subgroups - polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF). They are characterized by abnormal hematopoietic proliferation and an increased risk of leukemic transformation. In addition to the driver mutations JAK2, CALR, and MPL, more than twenty additional mutations have been identified through next-generation sequencing (NGS), which may be involved in pathways related to epigenetic modifications, RNA splicing, or DNA repair. This review highlights the impact of molecular biology on the diagnosis, prognosis, and therapeutic management of PV, ET, and PMF patients.

CELLS (2023)

Add to Collection

Review Oncology

Advances in germline predisposition to acute leukaemias and myeloid neoplasms

Jeffery M. Klco, Charles C. Mullighan

Summary: This review emphasizes the different genetic pathways impacted by germline mutations leading to the development of familial and sporadic haematological malignancies, with a particular focus on recent advances in acute lymphoblastic leukaemia, acute myeloid leukaemia, and myelodysplastic syndromes.

NATURE REVIEWS CANCER (2021)

Add to Collection

Review Oncology

Genetic Aspects of Myelodysplastic/Myeloproliferative Neoplasms

Laura Palomo, Pamela Acha, Francesc Sole

Summary: Myelodysplastic/myeloproliferative neoplasms (MDS/MPN) are characterized by overlapping features from both myelodysplastic syndromes and myeloproliferative neoplasms. The majority of patients with this disease have mutations in common myeloid neoplasm genes, which play a role in clinical heterogeneity and evolution.

CANCERS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Production and Characterization of Peptide Antibodies to the C-Terminal of Frameshifted Calreticulin Associated with Myeloproliferative Diseases

Farah Perveen Mughal, Ann Christina Bergmann, Ha Uyen Buu Huynh, Sarah Hyllekvist Jorgensen, Inaam Mansha, Meliha Kesmez, Patrick Mark Schurch, Alexandre Pierre Andre Theocharides, Paul Robert Hansen, Tina Friis, Morten Orebo Holmstrom, Evaldas Ciplys, Rimantas Slibinskas, Peter Hojrup, Gunnar Houen, Nicole Hartwig Trier

Summary: This study generated and characterized eight peptide antibodies targeting the C-terminal of CRTfs, which are important tools for understanding the molecular mechanisms of MPNs and developing new diagnostic assays and therapies.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Article Oncology

Arginase-1+bone marrow myeloid cells are reduced in myeloproliferative neoplasms and correlate with clinical phenotype, fibrosis, and molecular driver

Arturo Bonometti, Oscar Borsani, Elisa Rumi, Virginia Valeria Ferretti, Claudia Dioli, Elena Lucato, Marco Paulli, Emanuela Boveri

Summary: This study investigated the clinical and prognostic significance of Arginase-1 immunosuppressive myeloid cells in the bone marrow of MPN patients. The reduction of these cells was found to be associated with various clinical and histopathological features, as well as the presence of CALR mutations. Furthermore, it was speculated that these cells may migrate to the spleen and exert systemic immunomodulatory function.

CANCER MEDICINE (2023)

Add to Collection

Article Biochemistry & Molecular Biology

Epigenetic CpG duplex marks probed by an evolved DNA reader via a well-tempered conformational plasticity

Himanshu Singh, Chandan K. Das, Benjamin C. Buchmuller, Lars Schaefer, Daniel Summerer, Rasmus Linser

Summary: Researchers have discovered that 5-methylcytosine (mC) and its TET-oxidized derivatives exist in CpG dyads of mammalian DNA and regulate cell fate, but how they function as distinct regulatory signals is not well understood. Designing readers that selectively recognize these novel 'CpG duplex marks' presents a challenge due to their unprecedented selectivity requirements. This study demonstrates the importance of precise conformational plasticity for the selectivity of a designer reader for an oxidized CpG duplex mark.

NUCLEIC ACIDS RESEARCH (2023)

Add to Collection

Review Medicine, General & Internal

Acute Myeloid Leukemia Evolving from Myeloproliferative Neoplasms: Many Sides of a Challenging Disease

Francesco Mannelli

Summary: The evolution to blast phase in myeloproliferative neoplasms is often unpredictable and fatal, with unclear molecular mechanisms. Current therapeutic approaches are inadequate in modifying the unfavorable outcome, and targeted strategies to prevent leukemic evolution and allocation to allogeneic transplant for eligible patients should be pursued. Novel combination treatments may also provide useful bridging strategies for improving outcomes.

JOURNAL OF CLINICAL MEDICINE (2021)

Add to Collection

Letter Hematology

Donor cell-derived myelofibrosis relapse after allogeneic stem cell transplantation

Patrizia Chiusolo, Nicoletta Orlando, Sabrina Giammarco, Monica Rossi, Elisabetta Metafuni, Salvatore Leotta, Giuseppe Milone, Caterina Giovanna Valentini, Maria Bianchi, Filippo Frioni, Claudio Pellegrino, Federica Sora, Luigi Maria Larocca, Simona Sica, Andrea Bacigalupo, Luciana Teofili

HAEMATOLOGICA (2023)

Add to Collection

Letter Oncology

Outcome prediction in myelodysplastic neoplasm undergoing hematopoietic cell transplant in the molecular era of IPSS-M

Carmelo Gurnari, Nico Gagelmann, Anita Badbaran, Hussein Awada, Danai Dima, Simona Pagliuca, Maud D'Aveni-Piney, Enrico Attardi, Maria Teresa Voso, Raffaella Cerretti, Christine Wolschke, Marie Therese Rubio, Jaroslaw P. Maciejewski, Nicolaus Kroeger

LEUKEMIA (2023)

Add to Collection

Letter Hematology

Coagulopathy in Patients with Low/Intermediate Risk Acute Promyelocytic Leukemia treated with First Line Arsenic Trioxide in Combination with All-Trans Retinoic Acid: A Monocentric Experience

Francesco Autore, Patrizia Chiusolo, Federica Sora, Luca Laurenti, Livio Pagano, Andrea Bacigalupo, Valerio De Stefano, Simona Sica

MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES (2023)

Add to Collection

Meeting Abstract Oncology

THE GENE EXPRESSION PROFILE OF GENES BELONGING TO TRANSFORMING GROWTH FACTOR-B PATHWAY IS DEREGULATED IN SF3B1 MUTATED LOW-RISK MDS PATIENTS

E. Fabiani, H. Hajrullaj, A. Cristiano, G. Silvestrini, E. Galossi, G. Falconi, S. Hutter, N. Nadarajah, L. Maurillo, R. Latagliata, T. Haferlach, M. T. Voso

LEUKEMIA RESEARCH (2023)

Add to Collection

Meeting Abstract Oncology

KENNEDY'S DISEASE AND MYELODISPLASTIC SYNDROME: A POSSIBLE NEW ENTITY IN MYELOID NEOPLASM GERMLINE PREDISPOSITION. A CASE REPORT

A. L. Piccioni, S. Fenu, M. T. Voso, M. Inghilleri, E. Fabiani, P. Panetta, B. Anaclerico, P. Anticoli Borza, V. Bongarzoni, M. Cedrone, E. Ceresoli, E. Finolezzi, S. Leonetti Crescenzi, A. Tamburini, L. Cudillo

LEUKEMIA RESEARCH (2023)

Add to Collection

Meeting Abstract Oncology

CORRELATIONS BETWEEN IMMUNOLOGICAL AND MUTATIONAL PROFILE IN MYELODYSPLASTIC SYNDROME

A. Cristiano, R. Belardi, H. Hajrullaj, C. Gurnari, G. Falconi, E. Galossi, S. Fenu, E. Attardi, E. Fabiani, M. T. Voso, M. Nuccetelli

LEUKEMIA RESEARCH (2023)

Add to Collection

Review Hematology

Peripheral Blood Allogeneic Stem Cell Mobilization: Can We Predict a Suboptimal Mobilization?

Nicola Piccirillo, Rossana Putzulu, Elisabetta Metafuni, Giuseppina Massini, Federica Fatone, Andrea Corbingi, Sabrina Giammarco, Maria Assunta Limongiello, Alessia Di Giovanni, Gina Zini, Andrea Bacigalupo, Luciana Teofili, Simona Sica, Patrizia Chiusolo

Summary: A study shows that early estimation of the success of peripheral blood stem cell collection can be achieved through genetic analysis and testing in donors, preventing risks and costs associated with suboptimal mobilization.

TRANSFUSION MEDICINE REVIEWS (2023)

Add to Collection

Editorial Material Oncology

Editorial: The latest advances in transplantation for AML

Patrizia Chiusolo, Fabio Ciceri, Simona Sica

FRONTIERS IN ONCOLOGY (2023)

Add to Collection

Article Oncology

YY1 Knockdown Relieves the Differentiation Block and Restores Apoptosis in AML Cells

Nelida Ines Noguera, Serena Travaglini, Stefania Scalea, Caterina Catalanotto, Anna Reale, Michele Zampieri, Alessandra Zaza, Maria Rosaria Ricciardi, Daniela Francesca Angelini, Agostino Tafuri, Tiziana Ottone, Maria Teresa Voso, Giuseppe Zardo

Summary: Acute myeloid leukemia (AML) is characterized by the expansion of clonally derived hematopoietic precursors undergoing a maturation block. The study shows that YY1, a member of the noncanonical PcG complexes, is significantly overexpressed in AML and knockdown of YY1 relieves the differentiation block in AML.

CANCERS (2023)

Add to Collection

Article Oncology

Multicenter Observational Retrospective Study on Febrile Events in Patients with Acute Myeloid Leukemia Treated with Cpx-351 in Real-Life: The SEIFEM Experience

Luana Fianchi, Fabio Guolo, Francesco Marchesi, Chiara Cattaneo, Michele Gottardi, Francesco Restuccia, Anna Candoni, Elettra Ortu La Barbera, Rita Fazzi, Crescenza Pasciolla, Olimpia Finizio, Nicola Fracchiolla, Mario Delia, Federica Lessi, Michelina Dargenio, Valentina Bonuomo, Maria Ilaria Del Principe, Patrizia Zappasodi, Marco Picardi, Claudia Basilico, Monica Piedimonte, Paola Minetto, Antonio Giordano, Patrizia Chiusolo, Lucia Prezioso, Caterina Buquicchio, Lorella Maria Antonia Melillo, Daniele Zama, Francesca Farina, Valentina Mancini, Irene Terrenato, Michela Rondoni, Irene Urbino, Mario Tumbarello, Alessandro Busca, Livio Pagano

Summary: This study evaluated the absolute infectious risk in 200 AML patients treated with CPX-351 and found it to have a good safety profile, with an incidence of infectious complications comparable to that of pivotal studies. The only factor significantly associated with mortality was a lack of response to CPX-351 treatment.

CANCERS (2023)

Add to Collection

Review Hematology

Bone Marrow Microenvironment Involvement in t-MN: Focus on Mesenchymal Stem Cells

Giulia Falconi, E. Galossi, H. Hajrullaj, E. Fabiani, M. T. Voso

Summary: Therapy-related myeloid neoplasms (t-MN) are a late complication of cytotoxic therapy (CT) used in the treatment of both malignant and non-malignant diseases. Among the factors contributing to t-MN development, the bone marrow microenvironment and bone marrow mesenchymal stem cells (BM-MSC) play important roles. BM-MSC support hematopoietic stem cells (HSC) and regulate the bone marrow immune microenvironment, but chemo/radiotherapy may damage BM-MSC and alter their functions, promoting malignant hematopoiesis.

MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES (2023)

Add to Collection

Review Microbiology

The Role of Fecal Microbiota Transplantation in the Allogeneic Stem Cell Transplant Setting

Elisabetta Metafuni, Luca Di Marino, Sabrina Giammarco, Silvia Bellesi, Maria Assunta Limongiello, Federica Sora, Filippo Frioni, Roberto Maggi, Patrizia Chiusolo, Simona Sica

Summary: This article reviews the changes in microbiota during allogeneic stem cell transplantation and the related treatment methods, focusing on the applications of fecal microbiota transplantation for graft-versus-host disease, multidrug-resistant and clostridium difficile infections, and microbiota restoration after chemotherapy and antibiotic therapy.

MICROORGANISMS (2023)

Add to Collection

Meeting Abstract Hematology

HOW TO INTERPRET NGS REPORTS IN THE DIAGNOSIS OF HEMATOLOGICAL NEOPLASMS

Patrizia Chiusolo

INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2023)

Add to Collection

Meeting Abstract Hematology

NGS TESTING IN ACUTE HEMATOLOGY NEOPLASMS

Patrizia Chiusolo

INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2023)

Add to Collection

Review Medicine, General & Internal

Red Blood Cell Exchange as a Valid Therapeutic Approach for Pregnancy Management in Sickle Cell Disease: Three Explicative Cases and Systematic Review of Literature

Caterina Giovanna Valentini, Claudio Pellegrino, Sara Ceglie, Vincenzo Arena, Francesca Di Landro, Patrizia Chiusolo, Luciana Teofili

Summary: Pregnancy in women with sickle cell disease (SCD) is a high-risk situation, requiring strict multidisciplinary follow-up. Transfusion support is the main treatment, while the use of automated red blood cell exchange (aRBCX) and other targeted methods is still controversial.

JOURNAL OF CLINICAL MEDICINE (2023)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.